Catastrophic antiphospholipid syndrome (CAPS)
Evidence-based neurology checklist on catastrophic antiphospholipid syndrome (caps): Pathology This occurs in 1% of the cases It results from microvascular occlusion It is a result of multiple thrombosis developing rapidly Risk factors Neurological features Systemic features Diagnostic criteria…
Pathology
- This occurs in 1% of the cases
- It results from microvascular occlusion
- It is a result of multiple thrombosis developing rapidly
Risk factors
Neurological features
Systemic features
Diagnostic criteria
Other differentials
Investigations
Treatment
Treatment of refractory cases
Outcome
References
- Stanescu C, Andronesi AG, Jurcut C, et al. Successful treatment of catastrophic antiphospholipid syndrome using rituximab: case report and review of the literature. Medicina (Kaunas) 2021; 57:912.
- Cervera R, Rodríguez-Pintó I, Espinosa G. The diagnosis and clinical management of the catstrophic antiphospholipid syndrome: a comprehensive review. J Autoimmun 2018; 92:1-11.
- Mustafa R. Neurologic manifestations of catastrophic antiphospholipid syndrome. Curr Neurol Neurosci Rep 2022; 22:589-600.
- Christopher N, Periaswamy G, Arunachalam VK, Mangalakumar V, Mehta P, Cherian M. Catastrophic antiphospholipid syndrome: a case series. Indian J Radiol Imaging 2022; 33:235-239.
- Kazzaz NM, McCune WJ, Knight JS. Treatment of catastrophic antiphospholipid syndrome. Curr Opin Rheumatol 2016; 28:218-227.
- And 2 more. Subscribe to see the full list
Related checklists
- Antiphospholipid syndrome (APS): neurological features
- Antiphospholipid syndrome (APS): systemic features
- Antiphospholipid syndrome (APS): differential diagnosis
- Antiphospholipid syndrome (APS): diagnostic criteria
- Antiphospholipid syndrome (APS): investigations
- Antiphospholipid syndrome (APS): treatment
